Fresenius Kabi: Malnutrition trials

The registry lists 13 Malnutrition studies with Fresenius Kabi as lead sponsor. 4 are open to participants now and 1 have results posted.

Phase 4 5No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Safety and Efficacy of Supportan® DrinkRecruitingNCT06902402Not applicable
• Suitability of a High-energy, Low-protein Formula (Renalive® LP)RecruitingNCT06892249Not applicable
• Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentRecruitingNCT06274788
• Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsRecruitingNCT06049680Phase 4
• Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of AgeTerminatedNCT03563222Phase 4Results posted
• Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)WithdrawnNCT04807478
• Nutrition Insights Day AsiaCompletedNCT03606603
• Study to Assess Safety and Efficacy of Kabiven® in Pediatric Patients 2 to 16 Years of AgeWithdrawnNCT03481894Phase 4
• Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer TherapyTerminatedNCT03355079Phase 4
• Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Scheduled IntakeCompletedNCT02938247Not applicable
• Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Free IntakeCompletedNCT02938234Not applicable
• Screening Day Latin AmericaCompletedNCT02583880
• Intradialytic Parenteral Nutrition in Hemodialysis PatientsCompletedNCT00501956Phase 4